Mara Sophie Vell (Mara S Vell)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Anti Inflammatory Drugs

Cardiovascular Events

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Hepatology communications

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Paul-Henry Koop, Constanze Schwenzer, Jan Clusmann, Mara Sophie Vell, Julius Jaeger, Wenfang Gui, Christian Trautwein, Alexander Koch, Karen Schmidt, Carolin Victoria Schneider, Kai Markus Schneider
Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis-A Phenome-Wide-Association-Study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Paul-Henry Koop, Constanze Schwenzer, Jan Clusmann, Mara Sophie Vell, Julius Jaeger, Wenfang Gui, Christian Trautwein, Alexander Koch, Karen Schmidt, Carolin Victoria Schneider, Kai Markus Schneider
Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis-A Phenome-Wide-Association-Study. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Mara Sophie Vell, Arunkumar Krishnan, Kirk J Wangensteen, Marina Serper, Katharina Sophie Seeling, Leonida Hehl, Miriam Daphne Rendel, Inuk Zandvakili, Marijana Vujkovic, Eleonora Scorletti, Kate Townsend Creasy, Christian Trautwein, Daniel James Rader, Saleh Alqahtani, Kai Markus Schneider, Carolin Victoria Schneider
Aspirin is associated with a reduced incidence of liver disease in men. Hepatology communications 7 (10) (2023)
Carolin Victoria Schneider, Leonida Hehl, Kate Townsend Creasy, Cecilia Vitali, Mara Sophie Vell, Marijana Vujkovic, Joe Park, Eleonora Scorletti, Katharina S Seeling, Miriam D Rendel, Donna M Conlon, Helen Huang, Inuk Zandvakili, Swati Valmiki, null null, Kai M Schneider, M Mahmood Hussain, Daniel J Rader
A coding variant in the microsomal triglyceride transfer protein reduces both hepatic steatosis and plasma lipids. Alimentary pharmacology & therapeutics (2023)